AXL and non-small cell lung carcinoma: Our experiments showed that a human NSCLC cell line, H1299, expressed high amounts of both AXL and phosphorylated AXL (p-AXL, an active form) and revealed that treating H1299 cells with AXL-targeted siRNA increased the average Young’s modulus value.